Carcinoma
MONDO:0004993A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.
Also known as: epithelioma, Other carcinoma, carcinoma, carcinoma, malignant, epithelial carcinoma, epithelioma malignant, malignant epithelial neoplasm, malignant epithelial tumor
16928 clinical trials for this condition and its sub-types, 224 tagged with Carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Carcinoma
-
Adenocarcinoma 184 trials · 5,243 incl. sub-types
64 sub-types
- Hepatocellular carcinoma 1,043 trials · 1,088 incl. sub-types Sub-types →
- Pancreatic adenocarcinoma 493 trials · 926 incl. sub-types Sub-types →
- Renal cell carcinoma 611 trials · 710 incl. sub-types Sub-types →
- Tubular adenocarcinoma 0 trials · 557 incl. sub-types Sub-types →
- Colorectal adenocarcinoma 246 trials · 546 incl. sub-types Sub-types →
- Gastroesophageal junction adenocarcinoma 506 trials
- Gastric adenocarcinoma 448 trials · 480 incl. sub-types Sub-types →
- Bile duct adenocarcinoma 17 trials · 416 incl. sub-types Sub-types →
- Prostate adenocarcinoma 297 trials Sub-types →
- Breast adenocarcinoma 36 trials · 278 incl. sub-types Sub-types →
- Serous adenocarcinoma 6 trials · 241 incl. sub-types Sub-types →
- Ovarian adenocarcinoma 12 trials · 230 incl. sub-types Sub-types →
- Clear cell adenocarcinoma 14 trials · 201 incl. sub-types Sub-types →
- Esophageal adenocarcinoma 168 trials · 172 incl. sub-types Sub-types →
- Adenocarcinoma in situ 10 trials · 170 incl. sub-types Sub-types →
- Endometrioid adenocarcinoma 12 trials · 144 incl. sub-types Sub-types →
- Endometrium adenocarcinoma 30 trials · 118 incl. sub-types Sub-types →
- Thyroid gland adenocarcinoma 0 trials · 118 incl. sub-types Sub-types →
- Lung adenocarcinoma 114 trials · 117 incl. sub-types Sub-types →
- Gastroesophageal adenocarcinoma 93 trials
- Papillary adenocarcinoma 2 trials · 92 incl. sub-types Sub-types →
- Fallopian tube adenocarcinoma 4 trials · 81 incl. sub-types Sub-types →
- Small intestine adenocarcinoma 18 trials · 60 incl. sub-types Sub-types →
- Mucinous adenocarcinoma 18 trials · 57 incl. sub-types Sub-types →
- Adenoid cystic carcinoma 46 trials · 47 incl. sub-types Sub-types →
- Cervical adenocarcinoma 27 trials · 34 incl. sub-types Sub-types →
- Poorly differentiated thyroid gland carcinoma 17 trials
- Acinar cell carcinoma 4 trials · 15 incl. sub-types Sub-types →
- Signet ring cell carcinoma 4 trials · 11 incl. sub-types Sub-types →
- Paget disease 2 trials · 9 incl. sub-types Sub-types →
- Gallbladder adenocarcinoma 9 trials Sub-types →
- Bladder adenocarcinoma 5 trials · 8 incl. sub-types Sub-types →
- Vaginal adenocarcinoma 7 trials Sub-types →
- Cystadenocarcinoma 0 trials · 6 incl. sub-types Sub-types →
- Diffuse type adenocarcinoma 1 trial · 6 incl. sub-types Sub-types →
- Vulvar adenocarcinoma 3 trials · 5 incl. sub-types Sub-types →
- Parathyroid gland carcinoma 4 trials
- Pituitary adenocarcinoma 3 trials Sub-types →
- Sebaceous adenocarcinoma 2 trials · 3 incl. sub-types Sub-types →
- Hepatoid adenocarcinoma 2 trials Sub-types →
- Mesonephric adenocarcinoma 2 trials Sub-types →
- Sweat gland carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Urethra adenocarcinoma 1 trial · 2 incl. sub-types Sub-types →
- Follicular variant thyroid gland papillary carcinoma 1 trial
- Micropapillary serous carcinoma 1 trial
- Nasal cavity adenocarcinoma 1 trial
- Seminal vesicle adenocarcinoma 1 trial
- Trabecular adenocarcinoma 1 trial
- Ureter adenocarcinoma 1 trial
- Adenoacanthoma 0 trials
- Epididymal adenocarcinoma 0 trials
- Ethmoid sinus adenocarcinoma 0 trials
- Granular cell carcinoma 0 trials
- Intestinal type adenocarcinoma 0 trials Sub-types →
- Lacrimal gland adenocarcinoma 0 trials Sub-types →
- Maxillary sinus adenocarcinoma 0 trials
- Middle ear adenocarcinoma 0 trials
- Minor salivary gland adenocarcinoma 0 trials Sub-types →
- Rete testis adenocarcinoma 0 trials
- Salivary gland basal cell adenocarcinoma 0 trials
- Scirrhous adenocarcinoma 0 trials
- Submandibular gland adenocarcinoma 0 trials
- Thymus gland adenocarcinoma 0 trials Sub-types →
- Villous adenocarcinoma 0 trials Sub-types →
-
Digestive system carcinoma 25 trials · 4,876 incl. sub-types
16 sub-types
- Carcinoma of liver and intrahepatic biliary tract 36 trials · 1,455 incl. sub-types Sub-types →
- Colorectal carcinoma 305 trials · 1,166 incl. sub-types Sub-types →
- Exocrine pancreatic carcinoma 205 trials · 1,033 incl. sub-types Sub-types →
- Gastric carcinoma 92 trials · 554 incl. sub-types Sub-types →
- Gastroesophageal junction adenocarcinoma 506 trials
- Carcinoma of esophagus 75 trials · 504 incl. sub-types Sub-types →
- Carcinoma of pharynx 3 trials · 455 incl. sub-types Sub-types →
- Oral cavity carcinoma 16 trials · 200 incl. sub-types Sub-types →
- Small intestine carcinoma 19 trials · 105 incl. sub-types Sub-types →
- Gallbladder carcinoma 40 trials · 48 incl. sub-types Sub-types →
- Intestine carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Pancreatic endocrine carcinoma 12 trials Sub-types →
- Digestive system mixed adenoneuroendocrine carcinoma 0 trials · 3 incl. sub-types Sub-types →
- Carcinoma of floor of mouth 1 trial · 2 incl. sub-types Sub-types →
- Maxillary sinus carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Ameloblastic carcinoma 0 trials
-
Lung carcinoma 137 trials · 3,320 incl. sub-types
10 sub-types
- Non-small cell lung carcinoma 2,721 trials · 2,834 incl. sub-types Sub-types →
- Small cell lung carcinoma 514 trials · 515 incl. sub-types Sub-types →
- Squamous cell lung carcinoma 65 trials · 145 incl. sub-types Sub-types →
- Bronchogenic carcinoma 25 trials Sub-types →
- Lung carcinoma in situ 2 trials · 3 incl. sub-types Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Asbestos-related lung carcinoma 0 trials
- Lung epithelial-myoepithelial carcinoma 0 trials
- Lung hilum carcinoma 0 trials
- Lung inflammatory myofibroblastic tumor 0 trials
-
Breast carcinoma 665 trials · 2,688 incl. sub-types
13 sub-types
- Breast carcinoma by gene expression profile 0 trials · 1,787 incl. sub-types Sub-types →
- Invasive breast carcinoma 324 trials · 412 incl. sub-types Sub-types →
- Breast adenocarcinoma 36 trials · 278 incl. sub-types Sub-types →
- Breast carcinoma in situ 76 trials · 204 incl. sub-types Sub-types →
- Female breast carcinoma 137 trials Sub-types →
- Male breast carcinoma 22 trials
- Hereditary breast carcinoma 10 trials Sub-types →
- Bilateral breast carcinoma 6 trials · 9 incl. sub-types Sub-types →
- Hormone-resistant breast carcinoma 5 trials
- Sporadic breast cancer 2 trials
- Ehrlich tumor carcinoma 0 trials
- Cribriform carcinoma of breast 0 trials Sub-types →
- Nipple carcinoma 0 trials Sub-types →
-
Squamous cell carcinoma 177 trials · 1,766 incl. sub-types
39 sub-types
- Head and neck squamous cell carcinoma 829 trials · 1,053 incl. sub-types Sub-types →
- Esophageal squamous cell carcinoma 303 trials · 304 incl. sub-types Sub-types →
- Skin squamous cell carcinoma 149 trials · 156 incl. sub-types Sub-types →
- Squamous cell lung carcinoma 65 trials · 145 incl. sub-types Sub-types →
- Human papillomavirus-related squamous cell carcinoma 115 trials · 116 incl. sub-types Sub-types →
- Colorectal squamous cell carcinoma 1 trial · 54 incl. sub-types Sub-types →
- Adenosquamous carcinoma 8 trials · 45 incl. sub-types Sub-types →
- Cervical squamous cell carcinoma 36 trials · 40 incl. sub-types Sub-types →
- Metastatic squamous cell carcinoma 39 trials
- Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types Sub-types →
- Vulvar squamous cell carcinoma 22 trials Sub-types →
- Squamous cell carcinoma of pancreas 3 trials · 13 incl. sub-types Sub-types →
- Bone squamous cell carcinoma 0 trials · 11 incl. sub-types Sub-types →
- Squamous carcinoma in situ 5 trials · 10 incl. sub-types Sub-types →
- Vaginal squamous cell carcinoma 8 trials
- Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types Sub-types →
- Bladder squamous cell carcinoma 5 trials Sub-types →
- Gastric squamous cell carcinoma 4 trials Sub-types →
- Papillary squamous carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Thyroid gland squamous cell carcinoma 4 trials
- Endometrial squamous cell carcinoma 0 trials · 2 incl. sub-types Sub-types →
- Ovarian squamous cell carcinoma 2 trials
- Urethra squamous cell carcinoma 2 trials Sub-types →
- Keratinizing squamous cell carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Pure squamous carcinoma of the urothelial tract 1 trial
- Scrotum squamous cell carcinoma 1 trial
- Squamous cell carcinoma of the small intestine 1 trial Sub-types →
- Ureter squamous cell carcinoma 1 trial
- Fallopian tube squamous cell carcinoma 0 trials
- Gallbladder squamous cell carcinoma 0 trials Sub-types →
- Prostate squamous cell carcinoma 0 trials Sub-types →
- Pseudoglandular squamous cell carcinoma 0 trials
- Renal pelvis squamous cell carcinoma 0 trials
- Sarcomatoid squamous cell carcinoma 0 trials Sub-types →
- Squamous cell breast carcinoma 0 trials Sub-types →
- Squamous cell carcinoma of liver and intrahepatic biliary tract 0 trials Sub-types →
- Squamous cell carcinoma of the corpus uteri 0 trials
- Thymus squamous cell carcinoma 0 trials Sub-types →
- Trachea squamous cell carcinoma 0 trials Sub-types →
-
Head and neck carcinoma 73 trials · 1,415 incl. sub-types
16 sub-types
- Head and neck squamous cell carcinoma 829 trials · 1,053 incl. sub-types Sub-types →
- Lip and oral cavity carcinoma 94 trials · 258 incl. sub-types Sub-types →
- Oropharyngeal carcinoma 99 trials · 242 incl. sub-types Sub-types →
- Nasopharyngeal carcinoma 210 trials · 211 incl. sub-types Sub-types →
- Hypopharyngeal carcinoma 35 trials · 86 incl. sub-types Sub-types →
- Nasal cavity and paranasal sinus carcinoma 21 trials · 44 incl. sub-types Sub-types →
- Nasal cavity carcinoma 3 trials · 9 incl. sub-types Sub-types →
- Eye carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Pituitary adenocarcinoma 3 trials Sub-types →
- Carcinoma of floor of mouth 1 trial · 2 incl. sub-types Sub-types →
- External ear carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Middle ear carcinoma 1 trial Sub-types →
- Ameloblastic carcinoma 0 trials
- Growth hormone-producing pituitary gland carcinoma 0 trials
- Laryngeal small cell carcinoma 0 trials
- Pharyngeal adenoid cystic carcinoma 0 trials
-
Prostate carcinoma 394 trials · 1,321 incl. sub-types
9 sub-types
- Metastatic prostate carcinoma 670 trials
- Castration-resistant prostate carcinoma 478 trials
- Prostate adenocarcinoma 297 trials Sub-types →
- Hormone-resistant prostate carcinoma 30 trials
- Prostate small cell carcinoma 9 trials
- Familial prostate carcinoma 0 trials
- Grade III prostatic intraepithelial neoplasia 0 trials
- Primary prostate urothelial carcinoma 0 trials Sub-types →
- Prostate squamous cell carcinoma 0 trials Sub-types →
-
Renal carcinoma 85 trials · 764 incl. sub-types
3 sub-types
- Renal cell carcinoma 611 trials · 710 incl. sub-types Sub-types →
- Renal pelvis carcinoma 15 trials · 22 incl. sub-types Sub-types →
- Kidney carcinoma in situ 0 trials Sub-types →
-
Neuroendocrine carcinoma 106 trials · 744 incl. sub-types
12 sub-types
- Small cell carcinoma 26 trials · 542 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Medullary thyroid gland carcinoma 42 trials · 53 incl. sub-types Sub-types →
- Large cell neuroendocrine carcinoma 12 trials · 31 incl. sub-types Sub-types →
- Pancreatic endocrine carcinoma 12 trials Sub-types →
- Malignant adrenal gland pheochromocytoma 11 trials
- Liver neuroendocrine carcinoma 3 trials Sub-types →
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Goblet cell carcinoma 2 trials
- Anal canal neuroendocrine neoplasm 1 trial Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
-
Transitional cell carcinoma 249 trials · 721 incl. sub-types
9 sub-types
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Fallopian tube transitional cell carcinoma 12 trials
- Ovarian transitional cell carcinoma 12 trials
- Papillary transitional cell carcinoma 1 trial · 11 incl. sub-types Sub-types →
- Sarcomatoid transitional cell carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Bartholin gland transitional cell carcinoma 1 trial
- Endometrial transitional cell carcinoma 1 trial
- Primary prostate urothelial carcinoma 0 trials Sub-types →
- Transitional cell carcinoma of the corpus uteri 0 trials
-
Urinary bladder carcinoma 392 trials · 669 incl. sub-types
9 sub-types
- Bladder transitional cell carcinoma 130 trials · 408 incl. sub-types Sub-types →
- Superficial urinary bladder carcinoma 76 trials
- Stage IVb bladder cancer 39 trials
- Urinary bladder small cell neuroendocrine carcinoma 9 trials
- Bladder adenocarcinoma 5 trials · 8 incl. sub-types Sub-types →
- Bladder urachal carcinoma 3 trials · 6 incl. sub-types Sub-types →
- Bladder squamous cell carcinoma 5 trials Sub-types →
- Bladder small cell carcinoma 0 trials
- Childhood bladder carcinoma 0 trials
-
Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types
6 sub-types
- Ovarian carcinoma 493 trials · 642 incl. sub-types Sub-types →
- Malignant ovarian serous tumor 5 trials · 202 incl. sub-types Sub-types →
- Ovarian endometrial cancer 4 trials · 88 incl. sub-types Sub-types →
- Ovarian clear cell cancer 30 trials · 51 incl. sub-types Sub-types →
- Mucinous ovarian cancer 2 trials · 16 incl. sub-types Sub-types →
- Malignant ovarian Brenner tumor 2 trials
-
Uterine carcinoma 3 trials · 611 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- Endometrial carcinoma 207 trials · 313 incl. sub-types Sub-types →
- Endometrial serous adenocarcinoma 36 trials
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
-
Invasive carcinoma 4 trials · 604 incl. sub-types
4 sub-types
- Invasive breast carcinoma 324 trials · 412 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Invasive malignant thymoma 4 trials
- Submucosal invasive colon adenocarcinoma 0 trials
-
Peritoneal carcinoma 16 trials · 389 incl. sub-types
3 sub-types
- Primary peritoneal carcinoma 351 trials · 361 incl. sub-types Sub-types →
- Peritoneal serous adenocarcinoma 2 trials · 39 incl. sub-types Sub-types →
- Pseudomyxoma peritonei 17 trials
-
In situ carcinoma 25 trials · 318 incl. sub-types
21 sub-types
- Breast carcinoma in situ 76 trials · 204 incl. sub-types Sub-types →
- Adenocarcinoma in situ 10 trials · 170 incl. sub-types Sub-types →
- Bladder carcinoma in situ 30 trials
- Intestine carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Esophagus carcinoma in situ 13 trials
- Squamous carcinoma in situ 5 trials · 10 incl. sub-types Sub-types →
- Skin carcinoma in situ 3 trials · 9 incl. sub-types Sub-types →
- Oral cavity carcinoma in situ 5 trials Sub-types →
- Stomach carcinoma in situ 4 trials Sub-types →
- Lung carcinoma in situ 2 trials · 3 incl. sub-types Sub-types →
- Pharynx carcinoma in situ 0 trials · 2 incl. sub-types Sub-types →
- Larynx carcinoma in situ 1 trial Sub-types →
- Carcinoma in situ of ureter 0 trials
- Carcinoma in situ of urethra 0 trials
- Eye carcinoma in situ 0 trials
- Gall bladder carcinoma in situ 0 trials
- Grade III prostatic intraepithelial neoplasia 0 trials
- Kidney carcinoma in situ 0 trials Sub-types →
- Liver carcinoma in situ 0 trials Sub-types →
- Nasal cavity carcinoma in situ 0 trials
-
Skin carcinoma 34 trials · 281 incl. sub-types
13 sub-types
- Skin squamous cell carcinoma 149 trials · 156 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Skin basal cell carcinoma 51 trials · 59 incl. sub-types Sub-types →
- Skin carcinoma in situ 3 trials · 9 incl. sub-types Sub-types →
- Anal margin carcinoma 1 trial · 6 incl. sub-types Sub-types →
- Skin appendage carcinoma 4 trials · 6 incl. sub-types Sub-types →
- Eyelid carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Cutaneous Paget disease 0 trials · 1 incl. sub-types Sub-types →
- Borst-Jadassohn intraepidermal carcinoma 0 trials
- Cutaneous mucoepidermoid carcinoma 0 trials
- Labia majora carcinoma 0 trials
- Labia minora carcinoma 0 trials
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Thyroid gland carcinoma 41 trials · 237 incl. sub-types
11 sub-types
- Differentiated thyroid carcinoma 79 trials · 182 incl. sub-types Sub-types →
- Thyroid gland adenocarcinoma 0 trials · 118 incl. sub-types Sub-types →
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Multiple endocrine neoplasia type 2 4 trials · 30 incl. sub-types Sub-types →
- Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types Sub-types →
- Thyroid gland squamous cell carcinoma 4 trials
- Intrathyroid thymic carcinoma 0 trials
- Thyroid gland cribriform morular carcinoma 0 trials
- Thyroid gland mixed medullary and follicular cell-derived carcinoma 0 trials
- Thyroid gland mucinous carcinoma 0 trials
- Thyroid gland spindle cell tumor with thymus-like differentiation 0 trials
-
Fallopian tube carcinoma 126 trials · 182 incl. sub-types
6 sub-types
- Fallopian tube adenocarcinoma 4 trials · 81 incl. sub-types Sub-types →
- Fallopian tube transitional cell carcinoma 12 trials
- Fallopian tube carcinosarcoma 8 trials
- Fallopian tube gestational choriocarcinoma 0 trials
- Fallopian tube squamous cell carcinoma 0 trials
- Hereditary fallopian tube carcinoma 0 trials
-
Secondary carcinoma 1 trial · 169 incl. sub-types
1 sub-type
- Metastatic carcinoma 22 trials · 168 incl. sub-types Sub-types →
-
Bone carcinoma 0 trials · 131 incl. sub-types
7 sub-types
- Metastatic carcinoma in the bone 107 trials
- Paranasal sinus carcinoma 4 trials · 21 incl. sub-types Sub-types →
- Bone squamous cell carcinoma 0 trials · 11 incl. sub-types Sub-types →
- Pituitary adenocarcinoma 3 trials Sub-types →
- Adamantinoma 0 trials Sub-types →
- Growth hormone-producing pituitary gland carcinoma 0 trials
- Osteosarcoma arising in bone Paget disease 0 trials
-
Basal cell carcinoma 111 trials · 120 incl. sub-types
1 sub-type
- Skin basal cell carcinoma 51 trials · 59 incl. sub-types Sub-types →
-
Laryngeal carcinoma 56 trials · 114 incl. sub-types
8 sub-types
- Laryngeal squamous cell carcinoma 72 trials · 77 incl. sub-types Sub-types →
- Glottis carcinoma 6 trials · 10 incl. sub-types Sub-types →
- Carcinoma of supraglottis 1 trial · 2 incl. sub-types Sub-types →
- Larynx carcinoma in situ 1 trial Sub-types →
- Subglottis carcinoma 1 trial Sub-types →
- Laryngeal adenoid cystic carcinoma 0 trials
- Laryngeal mucoepidermoid carcinoma 0 trials
- Laryngeal small cell carcinoma 0 trials
-
Papillary carcinoma 8 trials · 112 incl. sub-types
5 sub-types
- Papillary adenocarcinoma 2 trials · 92 incl. sub-types Sub-types →
- Papillary transitional cell carcinoma 1 trial · 11 incl. sub-types Sub-types →
- Papillary squamous carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Papillary carcinoma of the cervix uteri 0 trials Sub-types →
- Papillary carcinoma of the corpus uteri 0 trials
-
Large cell carcinoma 2 trials · 87 incl. sub-types
5 sub-types
- Lung large cell carcinoma 11 trials · 37 incl. sub-types Sub-types →
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Large cell neuroendocrine carcinoma 12 trials · 31 incl. sub-types Sub-types →
- Nasopharyngeal type undifferentiated carcinoma 2 trials · 3 incl. sub-types Sub-types →
- Salivary gland large cell carcinoma 0 trials
-
Undifferentiated carcinoma 6 trials · 80 incl. sub-types
14 sub-types
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Undifferentiated ovarian carcinoma 13 trials
- Endometrial undifferentiated carcinoma 9 trials
- Undifferentiated carcinoma of nasopharynx 7 trials
- Nut midline carcinoma 6 trials
- Sinonasal undifferentiated carcinoma 6 trials
- Undifferentiated carcinoma of esophagus 1 trial
- Undifferentiated carcinoma of liver and intrahepatic biliary tract 1 trial
- Undifferentiated carcinoma of stomach 1 trial
- Undifferentiated pancreatic carcinoma 1 trial Sub-types →
- Salivary gland large cell carcinoma 0 trials
- Thymic undifferentiated carcinoma 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
- Undifferentiated gallbladder carcinoma 0 trials
-
Mucin-producing carcinoma 0 trials · 58 incl. sub-types
2 sub-types
- Mucinous adenocarcinoma 18 trials · 57 incl. sub-types Sub-types →
- Pancreatic mucinous cystadenoma 1 trial
-
Retroperitoneum carcinoma 0 trials · 52 incl. sub-types
1 sub-type
- Adrenal carcinoma 34 trials · 52 incl. sub-types Sub-types →
-
Vulvar carcinoma 24 trials · 45 incl. sub-types
9 sub-types
- Vulvar squamous cell carcinoma 22 trials Sub-types →
- Vulvar adenocarcinoma 3 trials · 5 incl. sub-types Sub-types →
- Bartholin gland carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Clitoral carcinoma 0 trials
- Labia majora carcinoma 0 trials
- Labia minora carcinoma 0 trials
- Vulva basal cell carcinoma 0 trials
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Thymic carcinoma 41 trials · 44 incl. sub-types
9 sub-types
- Invasive malignant thymoma 4 trials
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Lymphoepithelioma-like thymic carcinoma 0 trials
- Malignant type AB thymoma 0 trials
- Thymic sarcomatoid carcinoma 0 trials
- Thymic undifferentiated carcinoma 0 trials
- Thymus clear cell carcinoma 0 trials
- Thymus gland adenocarcinoma 0 trials Sub-types →
- Thymus squamous cell carcinoma 0 trials Sub-types →
-
Penile carcinoma 9 trials · 35 incl. sub-types
3 sub-types
- Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types Sub-types →
- Paget disease of the penis 0 trials
- Penis basal cell carcinoma 0 trials
-
Sarcomatoid carcinoma 1 trial · 26 incl. sub-types
8 sub-types
- Sarcomatoid renal cell carcinoma 15 trials
- Lung sarcomatoid carcinoma 3 trials · 7 incl. sub-types Sub-types →
- Sarcomatoid transitional cell carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Pleomorphic carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Rectal sarcomatoid carcinoma 0 trials
- Sarcomatoid basal cell carcinoma 0 trials
- Sarcomatoid squamous cell carcinoma 0 trials Sub-types →
- Thymic sarcomatoid carcinoma 0 trials
-
Vaginal carcinoma 12 trials · 22 incl. sub-types
2 sub-types
- Vaginal squamous cell carcinoma 8 trials
- Vaginal adenocarcinoma 7 trials Sub-types →
-
Carcinoma of urethra 2 trials · 21 incl. sub-types
5 sub-types
- Urethra transitional cell carcinoma 17 trials Sub-types →
- Urethra adenocarcinoma 1 trial · 2 incl. sub-types Sub-types →
- Urethra squamous cell carcinoma 2 trials Sub-types →
- Littre gland carcinoma 0 trials Sub-types →
- Carcinoma in situ of urethra 0 trials
-
Ureter carcinoma 1 trial · 19 incl. sub-types
6 sub-types
- Ureter transitional cell carcinoma 16 trials Sub-types →
- Ureter adenocarcinoma 1 trial
- Ureter small cell carcinoma 1 trial
- Ureter squamous cell carcinoma 1 trial
- Carcinoma in situ of ureter 0 trials
- Regional ureteric cancer 0 trials
-
Choroid plexus carcinoma 11 trials
1 sub-type
-
Basaloid carcinoma 0 trials · 5 incl. sub-types
2 sub-types
- Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types Sub-types →
- Basaloid large cell lung carcinoma 0 trials
-
Cribriform carcinoma 1 trial · 4 incl. sub-types
2 sub-types
- Salivary duct carcinoma 3 trials
- Cribriform carcinoma of breast 0 trials Sub-types →
-
Malignant myoepithelioma 2 trials
1 sub-type
- Malignant breast myoepithelioma 0 trials
-
Combined carcinoid and adenocarcinoma 0 trials · 2 incl. sub-types
1 sub-type
- Goblet cell carcinoma 2 trials
-
Carcinoma ex pleomorphic adenoma 1 trial
2 sub-types
-
Trachea carcinoma 1 trial
3 sub-types
- Trachea mucoepidermoid carcinoma 0 trials
- Trachea squamous cell carcinoma 0 trials Sub-types →
- Tracheal adenoid cystic carcinoma 0 trials
-
Scrotal carcinoma 0 trials · 1 incl. sub-types
3 sub-types
- Scrotum squamous cell carcinoma 1 trial
- Scrotum Paget disease 0 trials
- Scrotum basal cell carcinoma 0 trials
-
Krebs 2 carcinoma 0 trials
-
Comedocarcinoma 0 trials
-
Epithelial-myoepithelial carcinoma 0 trials
2 sub-types
-
Glycogen-rich carcinoma 0 trials
1 sub-type
-
Lipid-rich carcinoma 0 trials
1 sub-type
- Lipid-rich breast carcinoma 0 trials
-
Lymph node carcinoma 0 trials
Most studied deeper sub-types
-
New combo therapy shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested whether giving the immunotherapy drug durvalumab alongside radiation works better than the standard cetuximab plus radiation for people with advanced head and neck cancer who cannot take the usual chemotherapy drug cisplatin. A total of 196 adults took part. The…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a cheaper copy of keytruda work just as well against cancer?
Disease control CompletedThis study tests whether a new drug called RPH-075, a biosimilar of pembrolizumab (Keytruda), works as well as the original in people with skin melanoma, lung cancer, or head and neck cancer. Participants receive a single dose of either RPH-075 or Keytruda, and researchers compar…
Phase 1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy aims to stall lung cancer
Disease control CompletedThis phase 3 trial tests whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can help people with stage III lung cancer that cannot be removed by surgery. About 328 participants will receive either durvalumab or a placebo alongside their chemo …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Lung cancer trial tests olaparib as maintenance therapy
Disease control CompletedThis phase 3 trial tested whether adding the drug olaparib (Lynparza) to standard treatment with pembrolizumab (Keytruda) and chemotherapy helps people with advanced nonsquamous lung cancer live longer without their disease worsening. Over 1,000 participants received either olapa…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo therapy aims to stop liver cancer from coming back
Disease control CompletedThis study tests whether adding a targeted drug (Donafenib) and chemotherapy directly into the liver's blood supply can prevent liver cancer from returning after surgery. It includes adults with a single large tumor (≥5 cm) and microscopic blood vessel invasion, who are at high r…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control CompletedThis early-phase trial tested an experimental drug called KVA12123, given alone or with the immunotherapy Keytruda, in 40 adults with advanced solid tumors (like lung, breast, or colon cancer) that had stopped responding to standard treatments. The main goals were to check safety…
Phase 1/2 • Sponsor: Kineta Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to outperform chemo in Tough-to-Treat stomach cancer
Disease control CompletedThis phase 3 trial tested whether a combination of two drugs, regorafenib and nivolumab, helps people with advanced gastro-oesophageal cancer live longer than standard chemotherapy. The study included 462 adults whose cancer had stopped responding to prior treatments. The goal wa…
Phase 3 • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Cancer-Fighting virus shows promise in Hard-to-Treat ovarian cancer
Disease control CompletedThis study tested a new immunotherapy called Olvi-Vec, which uses a modified virus to attack cancer cells, in 46 patients with ovarian cancer that had come back or stopped responding to standard treatments. The goal was to see if the treatment was safe and could slow tumor growth…
Phase 1/2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Experimental 'In-Situ' vaccine aims to train immune system against three cancers
Disease control CompletedThis early-phase trial tested a combination of four therapies to see if they could safely boost the immune system to fight cancer. 17 adults with non-Hodgkin's lymphoma, metastatic breast cancer, or head & neck cancer received low-dose radiation and two immune-boosting drugs inje…
Phase 1/2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for mystery cancers: immunotherapy shows promise
Disease control CompletedThis study tested the immunotherapy drug pembrolizumab in 35 adults with cancer of unknown primary (CUP), a cancer that starts in an unknown location. Participants received the drug intravenously, and researchers measured how many saw their tumors shrink or disappear. The goal wa…
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New cocktail of drugs shows promise for tough pancreatic cancer
Disease control CompletedThis study tested a combination of four drugs (tadalafil, pembrolizumab, ipilimumab, and CRS-207) in 17 people with advanced pancreatic cancer that had worsened after at least one round of chemotherapy. The goal was to see if the combination was safe and could shrink tumors. The …
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Immunotherapy combo shows promise in advanced cervical cancer trial
Disease control CompletedThis phase 3 trial tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy and bevacizumab helps women with advanced, persistent, or recurrent cervical cancer live longer. The study enrolled 410 participants and compared the new combination against the …
Phase 3 • Sponsor: Grupo Español de Investigación en Cáncer de Ovario • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New targeted pill shows promise for rare lung cancer mutation
Disease control CompletedThis study tested a drug called capmatinib in 50 Indian adults with advanced non-small cell lung cancer that has a specific genetic change (MET exon 14 skipping mutation). The goal was to see how safe the drug is and how well it shrinks tumors. Participants took capmatinib pills,…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New Two-Drug cocktail shows promise against tough cancers
Disease control CompletedThis study tested a combination of two drugs—NT-I7 (efineptakin alfa) and pembrolizumab (Keytruda)—in 215 people with advanced solid tumors that had stopped responding to treatment. The goal was to check safety, find the right dose, and see if the combo could shrink tumors. The t…
Phase 1/2 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo shows promise for tough lung cancer
Disease control CompletedThis study tested whether adding the drug olaparib to standard treatment (pembrolizumab plus chemotherapy) helps people with advanced squamous non-small cell lung cancer live longer or keep the cancer from growing. About 850 adults who had not been treated before took part. The g…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Cialis and keytruda together against head and neck cancer: small trial shows promise?
Disease control CompletedThis completed phase II study tested a combination of two drugs—tadalafil (Cialis) and pembrolizumab (Keytruda)—in 7 adults with advanced head and neck cancer that had spread or come back. The goal was to see if the combination was safe and could help control the disease. Because…
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
First human trial of BI 765049 combo aims to fight hard-to-treat cancers
Disease control CompletedThis early-phase study tests two experimental drugs, BI 765049 and ezabenlimab, in adults with advanced solid tumors like colorectal, lung, and pancreatic cancer. The main goal is to find the highest safe dose of BI 765049 alone and in combination with ezabenlimab. Participants r…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail targets tough lung cancer mutation
Disease control CompletedThis phase 2 trial tested a combination of two oral drugs, RMC-4630 and sotorasib, in 47 adults with advanced KRASG12C-mutant non-small cell lung cancer that had progressed after standard treatments. The goal was to see if the combination could shrink tumors. The study is now com…
Phase 2 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Experimental virus therapy takes on advanced tumors in early trial
Disease control CompletedThis early-phase study tested a new treatment called NG-350A, a virus designed to target tumors and boost immune activity, combined with the immunotherapy drug pembrolizumab. Fourteen people with advanced epithelial cancers that had stopped responding to standard treatments recei…
Phase 1 • Sponsor: Akamis Bio • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Engineered t cells take on lung cancer in early trial
Disease control CompletedThis early-stage trial tested a new treatment for people with advanced non-small cell lung cancer that had grown after standard therapy. Researchers took patients' own immune cells, genetically modified them to recognize and attack cancer cells, and infused them back after chemot…
Phase 1 • Sponsor: Adaptimmune • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Gene-Edited immune cells take on Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a new treatment called CTX131 for adults with advanced solid tumors that have not responded to standard therapies. The treatment uses donor immune cells that are gene-edited to target a protein called CD70 found on cancer cells. The study enrolled 19…
Phase 1/2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New hope for advanced skin cancer: targeted pill tested in china
Disease control CompletedThis study tested a drug called sonidegib in 160 Chinese adults with a type of advanced skin cancer (basal cell carcinoma) that could not be treated with surgery or radiation. The drug is taken as a capsule and works by blocking signals that help cancer grow. The main goal was to…
Phase 4 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Experimental vaccines show promise against HPV-Driven cancers
Disease control CompletedThis completed phase I/II trial tested two experimental vaccines, HB-201 and HB-202, in 198 people with HPV 16+ cancers. The goal was to find a safe dose and see if the vaccines could shrink tumors. Participants received the vaccines alone or with standard treatments like pembrol…
Phase 1/2 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated Jun 26, 2026 17:14 UTC
-
Lung cancer drug combo fails to extend survival in major trial
Disease control CompletedThis large Phase 3 trial tested whether adding aflibercept (a drug that blocks blood vessel growth) to standard chemotherapy (docetaxel) could help people with advanced non-small cell lung cancer live longer. Over 900 participants who had already tried one platinum-based treatmen…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 15:45 UTC
-
Breakfast breakthrough? study tests if food can improve kidney cancer drug tolerability
Disease control CompletedThis study looked at whether taking the kidney cancer drug cabozantinib with a light breakfast changes how much drug gets into the body. Twelve patients with advanced kidney cancer took the drug both on an empty stomach and with a light breakfast, and researchers measured drug le…
Phase 2 • Sponsor: dr. Tom van der Hulle • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC
-
New blood test could spot lung cancer mutations more accurately
Diagnosis CompletedThis study tests a new, ultra-sensitive blood test (NGS) to detect EGFR gene mutations in patients with advanced lung cancer. Researchers will compare it to the current standard test using stored blood samples from 130 patients. The goal is to see if the new method finds more mut…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
New imaging tool may help detect Eye-Area skin cancer without a biopsy
Diagnosis CompletedThis study tested a non-invasive imaging device called dermal optical coherence tomography (D-OCT) to diagnose basal cell carcinoma (a common skin cancer) around the eye area. Researchers compared its accuracy to standard biopsy results in 210 adults with suspected lesions. The g…
Sponsor: Vejle Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New toolkit aims to boost recovery for older cancer surgery patients
Symptom relief CompletedThis study tests a pre-surgical toolkit (OPTI-Surg) designed to help older cancer patients recover more quickly after major surgery. The toolkit provides recommendations before surgery to improve physical function and reduce complications. About 325 participants with various canc…
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can talking it out ease PTSD in cancer patients during a pandemic?
Symptom relief CompletedThis study tested whether monthly 45-minute psychological interviews over 6 months could reduce post-traumatic stress symptoms in cancer patients affected by the COVID-19 pandemic. It included 29 adults with solid tumors who had moderate to high PTSD symptoms. The goal was to see…
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
New drug may ease severe skin rashes in cancer patients
Symptom relief CompletedThis study tested whether the drug benralizumab can safely reduce skin rashes caused by cancer treatments like checkpoint inhibitors. The goal was to lower the number of high-grade rashes to milder ones, which could improve quality of life and help patients stay on their cancer t…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can psychotherapy ease existential distress in advanced cancer?
Symptom relief CompletedThis study tested a short-term talking therapy (psychodynamic psychotherapy) for 24 adults with advanced solid tumors and high psychological distress. The goal was to see if the therapy is safe, acceptable, and feasible, not to cure the cancer. Results will help design larger stu…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Can money help cure cancer stress? new program targets financial toxicity
Symptom relief CompletedThis study tested a financial navigation program for cancer patients in rural and non-rural North Carolina. The program helped patients find financial assistance to reduce the burden of cancer costs. Researchers measured changes in financial toxicity and quality of life in 258 pa…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can a nationwide review unlock the secrets of a rare adrenal cancer?
Knowledge-focused CompletedThis study looks back at the medical records of 150 adults in Brazil diagnosed with adrenocortical carcinoma, a rare cancer of the adrenal glands. Researchers will collect details on age, gender, location, tumor stage, hormone activity, and treatments received since the year 2000…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a simple blood test guide cancer treatment? new study investigates.
Knowledge-focused CompletedThis study looks at whether analyzing the genes of a tumor (from a tissue sample or a blood test) can help doctors pick a more effective treatment for people with advanced solid cancers that have stopped responding to standard therapies. About 235 participants will have their tum…
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
What drives eyelid cancer in eastern morocco? a new study digs into the data
Knowledge-focused CompletedThis study reviews the medical records of 20 people treated for eyelid carcinomas at a hospital in eastern Morocco. Researchers are examining patient characteristics, tumor types, and surgical approaches to better understand how these cancers present and are managed in this regio…
Sponsor: Mohammed VI University Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Study aims to cut hospital time after liver surgery by looking beyond medicine
Knowledge-focused CompletedThis completed study looked at 3000 patients having liver surgery to see if considering both medical and social factors could reduce how long they stay in the hospital. Researchers tracked things like complications and readmissions. The goal is to find ways to improve recovery an…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New biomarker may predict which cancer drugs work best
Knowledge-focused CompletedThis completed study tested whether a new biomarker called 'mass response' can predict how well a cancer therapy will work. Researchers collected tumor cells from 72 patients with various cancers through fluid drainage or biopsies. The goal was to see if this biomarker could guid…
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Pesticide link to pancreatic cancer investigated in small study
Knowledge-focused CompletedThis study looked at whether organochlorine pesticides, which build up in body fat over time, are more common in people with pancreatic cancer. Researchers compared fat and urine samples from 56 patients undergoing surgery—some with pancreatic cancer and some without. The goal wa…
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New 3-D method could help grow cancer cells from a simple blood draw
Knowledge-focused CompletedThis completed study tested a 3-D cell culture method to isolate and grow circulating tumor cells (CTCs) from blood samples of 160 people with and without cancer. The goal was to see if this method could reliably expand CTC numbers for research. If it works, it could improve how …
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC